Simplex Castings Raises ₹6.25 Crore in Preferential Allotment

Simplex Castings Limited raised ₹6.25 crore on November 6, 2026 through the preferential allotment of 594,901 equity shares at ₹105 each to non-promoter investors. The company also allotted 163,809 convertible warrants, receiving ₹0.43 crore upfront and creating a potential additional inflow of ₹1.72 crore if the warrants are exercised.

What did Simplex Castings allot on November 6, 2026?

Simplex Castings allotted 594,901 equity shares of face value ₹2 each at an issue price of ₹105 per share, including a premium of ₹103 per share. The equity allotment raised ₹6.25 crore from non-promoter investors through a preferential issue disclosed under Regulation 30 of the Listing Obligations and Disclosure Requirements regulations.

The allottees included NAFA India Emerging Blue Chip Fund, Vishal Gupta, Mili Emerging Equities Fund, Apurva Narendrakumar Parekh, Resonance Opportunities Fund, Snehal Sunny Shah, Venus Investments VCC-Venus Stellar Fund, Paresh Dineshlal Shah, Niraj Deepak Dalal and Shah Amee D. Apurva Narendrakumar Parekh received the largest allotment of 154,285 equity shares, followed by Resonance Opportunities Fund with 96,428 shares.

The company separately allotted 163,809 fully convertible equity warrants at ₹105 each to four non-promoter allottees. Chandni Gupta received 47,619 warrants, Venus Investments VCC-Venus Stellar Fund received 76,190 warrants, and Saurabh Gupta and Akshit Lakhotia received 20,000 warrants each.

The disclosed total value of the equity shares and warrants is about ₹7.97 crore. That amount includes the full potential value of the warrants. The cash received at allotment includes ₹6.25 crore from shares and ₹0.43 crore as the required upfront payment on warrants.

How do the convertible warrants work?

Simplex Castings' warrants can be converted into equity shares at the warrant holders' discretion within 18 months from the allotment date. Each warrant is convertible into one equity share of face value ₹2 at the fixed price of ₹105, subject to adjustments allowed under applicable regulations.

Warrant holders paid 25% of the issue price upfront, which resulted in the company receiving ₹0.43 crore. The remaining 75% is payable only if holders elect to convert their warrants into equity shares during the 18-month window. If the conversion right is not exercised within that period, it will lapse and the upfront consideration will be forfeited under the stated terms.

The warrant allotment does not immediately alter Simplex Castings' paid-up equity capital, shareholding pattern or control. Dilution from these instruments will arise only if and when the 163,809 warrants are converted into equity shares. Investors assessing the transaction therefore need to separate the shares already issued from the potential shares linked to warrants.

The allotment followed the applicable preferential-issue framework referred to by the company, including the SEBI master circular dated January 30, 2026. The pricing for both the shares and warrants was ₹105 per security, comprising ₹2 face value and ₹103 premium.

What is the wider preferential fundraising plan?

Simplex Castings has a larger approved preferential fundraising plan covering up to 4,490,791 equity shares and 5,005,195 convertible warrants at ₹105 each. BSE granted in-principle approval for that proposed issuance on November 3, 2026, providing an exchange-level regulatory step for the capital-raising proposal.

At the stated issue price, the full equity-share component could raise up to ₹47.15 crore. The warrant component has a potential aggregate value of up to ₹52.55 crore upon conversion. Together, the proposed issue has a maximum potential value of ₹99.71 crore, although the approval does not mean the entire amount has been raised or that all warrants will be converted.

The board approved the proposal on September 23, 2026. It also approved an increase in authorised share capital to ₹15 crore and called an extraordinary general meeting for October 15, 2026 to seek shareholder approval. The equity shares in the broader proposal were intended for non-promoter investors, while the warrants were proposed for promoter and non-promoter categories.

The November 6 allotment represents a smaller issuance within this wider capital-raising process. It is distinct from the maximum quantities covered by BSE's in-principle approval, and its immediate financial effect is limited to the shares allotted and the warrant subscription money received.

Why does the allotment matter to investors and operations?

The allotment matters because Simplex Castings has added fresh equity capital of ₹6.25 crore and has potential access to a further ₹1.29 crore from the unpaid portion of the warrants if they are converted. The company has also introduced new non-promoter shareholders through the equity issue, while the warrants could increase its equity base later.

Simplex Castings had used preferential issues in earlier periods for stated operational and financing requirements. It allotted about ₹10.70 crore of preferential shares in August 2025 for loan repayment. In March 2026, it allotted about ₹21 crore of preferential shares for working-capital requirements related to railway bogie and power fabrication activities.

The current disclosure does not specify the use of proceeds for the November 6 allotment. It therefore provides confirmation of the funds raised and the securities issued, but not a new breakdown of how the cash will be deployed. The previously approved wider proposal establishes the scale of potential fundraising, while warrant conversion remains dependent on holders exercising their rights.

For shareholders, the immediate capital impact comes from 594,901 newly allotted equity shares. The future impact depends on the conversion of 163,809 warrants in this tranche and on any further allotments under the larger approved issue. No share-price movement or market reaction was disclosed with the allotment announcement.

Conclusion

Simplex Castings completed a preferential allotment that raised ₹6.25 crore through new equity shares and secured ₹0.43 crore in initial warrant subscriptions. The transaction has expanded the company's equity base, brought in non-promoter investors and left ₹1.29 crore of warrant consideration contingent on conversion.

The next point to watch is whether warrant holders exercise their conversion rights within 18 months and whether Simplex Castings makes further allotments under the BSE-approved plan of up to ₹99.71 crore. The company has not disclosed a fresh use-of-proceeds breakdown for the November 6 issue.